ImmunityBio (IBRX) Net Long-Term Debt Issued (Repaid) (2014 - 2026)
ImmunityBio's Non-Current Debt was $415.09 million in Q2 2026, up 35.2% from $307.05 million a year earlier and up 2.7% from the prior quarter.
Powered by 
Analysis
ImmunityBio (IBRX) Net Long-Term Debt Issued (Repaid) (2014 - 2026) Analysis & Trends
At the end of FY2025, Non-Current Debt at ImmunityBio came in at $324.62 million, up 14.1% from FY2024.
- Non-Current Debt shows a five-year compound annual growth rate of 5.0% (FY2020 to FY2025).
- In earlier years, Non-Current Debt was $284.4 million in FY2024 (+83.0%), $155.42 million in FY2023 and $306.35 million in FY2021 (+20.4%).
- The Q2 2026 figure marks the highest quarterly Non-Current Debt since Q3 2023.
- Compared with a year earlier, Non-Current Debt has increased for seven straight quarters, with growth averaging 29.9% over the last eight quarters.
- The best year-over-year quarter for Non-Current Debt over five years was Q3 2021 (growth of 506.5%); the worst was Q3 2024 (a decline of 43.0%).
- Per Business Quant data, IBRX's Non-Current Debt in the three quarters before Q2 2026 was $404.3 million (Q1 2026), $324.62 million (Q4 2025) and $316.15 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net LT Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | -1.00 Mn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 9.98 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 1.96 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | -3.05 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | -19.00 Mn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | - |
| 10 | ImmunityBio | 7.48 Bn | 6.24 Bn | 50.94 Mn | -103.18 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -103.18 Mn |
| Mar 31, 2026 | 176.35 Mn |
| Dec 31, 2025 | -1.14 Mn |
| Sep 30, 2025 | -12,000.00 |
| Jun 30, 2025 | -4,000.00 |
| Sep 30, 2024 | -22,000.00 |
| Jun 30, 2024 | 96.94 Mn |
| Mar 31, 2024 | -21,000.00 |
| Dec 31, 2023 | 192.74 Mn |
| Sep 30, 2023 | 198.98 Mn |
| Jun 30, 2023 | 29.83 Mn |
| Mar 31, 2023 | 29.83 Mn |
| Dec 31, 2022 | 49.73 Mn |
| Sep 30, 2022 | 124.34 Mn |
| Dec 31, 2021 | 298.50 Mn |
| Mar 31, 2021 | 40.00 Mn |
| Sep 30, 2020 | 63.70 Mn |
| Dec 31, 2018 | -142,000.00 |
| Sep 30, 2018 | -137,000.00 |
| Jun 30, 2018 | -133,000.00 |
API Access
ImmunityBio Net Long-Term Debt Issued (Repaid) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-debt&ticker=IBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-debt", "ticker": "IBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-debt&ticker=IBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();